Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2002 Mar 15;362(Pt 3):733–739. doi: 10.1042/0264-6021:3620733

The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study.

Jeannette Vásquez-Vivar 1, Pavel Martásek 1, Jennifer Whitsett 1, Joy Joseph 1, Balaraman Kalyanaraman 1
PMCID: PMC1222439  PMID: 11879202

Abstract

Augmentation of superoxide levels has been linked to impaired relaxation in hypertension, diabetes and hypercholesterolaemia. Purified endothelial nitric oxide synthase (eNOS) generates superoxide under limited availability of 5,6,7,8-tetrahydrobiopterin (BH(4)). Thus alterations in endothelial BH(4) levels have been postulated to stimulate superoxide production from eNOS. This possibility was examined by determining the concentration-dependent effects of BH(4), and its analogues, on superoxide formation by eNOS. Superoxide was quantified by EPR spin trapping, which is the only available technique to quantify superoxide from eNOS. Using 5-ethoxycarbonyl-5-methyl-pyrroline N-oxide, we show that only fully reduced BH(4) diminished superoxide release from eNOS, with efficiency BH(4)>6-methyl-BH(4)>5-methyl-BH(4). In contrast, partially oxidized BH(4) analogues, 7,8-dihydrobiopterin (7,8-BH(2)) and sepiapterin had no effect. Neither l-arginine nor N(G)-nitro-l-arginine methyl ester (l-NAME) abolished superoxide formation. Together, BH(4) and l-arginine stimulated .NO production at maximal rates of 148 nmol/min per mg of protein. These results indicate that BH(4) acts as a "redox switch", decreasing superoxide release and enhancing .NO formation. This role was verified by adding 7,8-BH(2) or sepiapterin to fully active eNOS. Both 7,8-BH(2) and sepiapterin enhanced superoxide release while inhibiting (.)NO formation. Collectively, these results indicate that the ratio between oxidized and reduced BH(4) metabolites tightly regulates superoxide formation from eNOS. The pathological significance of this scenario is discussed.

Full Text

The Full Text of this article is available as a PDF (190.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bec N., Gorren A. C., Voelker C., Mayer B., Lange R. Reaction of neuronal nitric-oxide synthase with oxygen at low temperature. Evidence for reductive activation of the oxy-ferrous complex by tetrahydrobiopterin. J Biol Chem. 1998 May 29;273(22):13502–13508. doi: 10.1074/jbc.273.22.13502. [DOI] [PubMed] [Google Scholar]
  2. Beckman J. S., Beckman T. W., Chen J., Marshall P. A., Freeman B. A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A. 1990 Feb;87(4):1620–1624. doi: 10.1073/pnas.87.4.1620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cosentino F., Sill J. C., Katusić Z. S. Role of superoxide anions in the mediation of endothelium-dependent contractions. Hypertension. 1994 Feb;23(2):229–235. doi: 10.1161/01.hyp.23.2.229. [DOI] [PubMed] [Google Scholar]
  4. Cuzzocrea S., Misko T. P., Costantino G., Mazzon E., Micali A., Caputi A. P., Macarthur H., Salvemini D. Beneficial effects of peroxynitrite decomposition catalyst in a rat model of splanchnic artery occlusion and reperfusion. FASEB J. 2000 Jun;14(9):1061–1072. doi: 10.1096/fasebj.14.9.1061. [DOI] [PubMed] [Google Scholar]
  5. Darley-Usmar V., Wiseman H., Halliwell B. Nitric oxide and oxygen radicals: a question of balance. FEBS Lett. 1995 Aug 7;369(2-3):131–135. doi: 10.1016/0014-5793(95)00764-z. [DOI] [PubMed] [Google Scholar]
  6. Duling D. R. Simulation of multiple isotropic spin-trap EPR spectra. J Magn Reson B. 1994 Jun;104(2):105–110. doi: 10.1006/jmrb.1994.1062. [DOI] [PubMed] [Google Scholar]
  7. Gokce N., Keaney J. F., Jr, Frei B., Holbrook M., Olesiak M., Zachariah B. J., Leeuwenburgh C., Heinecke J. W., Vita J. A. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 1999 Jun 29;99(25):3234–3240. doi: 10.1161/01.cir.99.25.3234. [DOI] [PubMed] [Google Scholar]
  8. Griendling K. K., Minieri C. A., Ollerenshaw J. D., Alexander R. W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994 Jun;74(6):1141–1148. doi: 10.1161/01.res.74.6.1141. [DOI] [PubMed] [Google Scholar]
  9. Guerra R., Jr, Brotherton A. F., Goodwin P. J., Clark C. R., Armstrong M. L., Harrison D. G. Mechanisms of abnormal endothelium-dependent vascular relaxation in atherosclerosis: implications for altered autocrine and paracrine functions of EDRF. Blood Vessels. 1989;26(5):300–314. doi: 10.1159/000158779. [DOI] [PubMed] [Google Scholar]
  10. Heitzer T., Brockhoff C., Mayer B., Warnholtz A., Mollnau H., Henne S., Meinertz T., Münzel T. Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers : evidence for a dysfunctional nitric oxide synthase. Circ Res. 2000 Feb 4;86(2):E36–E41. doi: 10.1161/01.res.86.2.e36. [DOI] [PubMed] [Google Scholar]
  11. Heitzer T., Krohn K., Albers S., Meinertz T. Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus. Diabetologia. 2000 Nov;43(11):1435–1438. doi: 10.1007/s001250051551. [DOI] [PubMed] [Google Scholar]
  12. Huang L., Abu-Soud H. M., Hille R., Stuehr D. J. Nitric oxide-generated P420 nitric oxide synthase: characterization and roles for tetrahydrobiopterin and substrate in protecting against or reversing the P420 conversion. Biochemistry. 1999 Feb 9;38(6):1912–1920. doi: 10.1021/bi981954t. [DOI] [PubMed] [Google Scholar]
  13. Ignarro L. J., Buga G. M., Wood K. S., Byrns R. E., Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A. 1987 Dec;84(24):9265–9269. doi: 10.1073/pnas.84.24.9265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Jiang J., Valen G., Tokuno S., Thorén P., Pernow J. Endothelial dysfunction in atherosclerotic mice: improved relaxation by combined supplementation with L-arginine-tetrahydrobiopterin and enhanced vasoconstriction by endothelin. Br J Pharmacol. 2000 Dec;131(7):1255–1261. doi: 10.1038/sj.bjp.0703705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kakoki M., Hirata Y., Hayakawa H., Suzuki E., Nagata D., Tojo A., Nishimatsu H., Nakanishi N., Hattori Y., Kikuchi K. Effects of tetrahydrobiopterin on endothelial dysfunction in rats with ischemic acute renal failure. J Am Soc Nephrol. 2000 Feb;11(2):301–309. doi: 10.1681/ASN.V112301. [DOI] [PubMed] [Google Scholar]
  16. Kinoshita H., Tsutsui M., Milstien S., Katusic Z. S. Tetrahydrobiopterin, nitric oxide and regulation of cerebral arterial tone. Prog Neurobiol. 1997 Jul;52(4):295–302. doi: 10.1016/s0301-0082(97)00017-8. [DOI] [PubMed] [Google Scholar]
  17. Kojda G., Harrison D. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res. 1999 Aug 15;43(3):562–571. doi: 10.1016/s0008-6363(99)00169-8. [DOI] [PubMed] [Google Scholar]
  18. Kunsch C., Medford R. M. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res. 1999 Oct 15;85(8):753–766. doi: 10.1161/01.res.85.8.753. [DOI] [PubMed] [Google Scholar]
  19. Liao D. F., Jin Z. G., Baas A. S., Daum G., Gygi S. P., Aebersold R., Berk B. C. Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells. J Biol Chem. 2000 Jan 7;275(1):189–196. doi: 10.1074/jbc.275.1.189. [DOI] [PubMed] [Google Scholar]
  20. Maier W., Cosentino F., Lütolf R. B., Fleisch M., Seiler C., Hess O. M., Meier B., Lüscher T. F. Tetrahydrobiopterin improves endothelial function in patients with coronary artery disease. J Cardiovasc Pharmacol. 2000 Feb;35(2):173–178. doi: 10.1097/00005344-200002000-00001. [DOI] [PubMed] [Google Scholar]
  21. Mayer B., Wu C., Gorren A. C., Pfeiffer S., Schmidt K., Clark P., Stuehr D. J., Werner E. R. Tetrahydrobiopterin binding to macrophage inducible nitric oxide synthase: heme spin shift and dimer stabilization by the potent pterin antagonist 4-amino-tetrahydrobiopterin. Biochemistry. 1997 Jul 8;36(27):8422–8427. doi: 10.1021/bi970144z. [DOI] [PubMed] [Google Scholar]
  22. Olive G., Mercier A., Le Moigne F., Rockenbauer A., Tordo P. 2-ethoxycarbonyl-2-methyl-3,4-dihydro-2H-pyrrole-1-oxide: evaluation of the spin trapping properties. Free Radic Biol Med. 2000 Feb 1;28(3):403–408. doi: 10.1016/s0891-5849(99)00254-3. [DOI] [PubMed] [Google Scholar]
  23. Palmer R. M., Ferrige A. G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987 Jun 11;327(6122):524–526. doi: 10.1038/327524a0. [DOI] [PubMed] [Google Scholar]
  24. Presta A., Siddhanta U., Wu C., Sennequier N., Huang L., Abu-Soud H. M., Erzurum S., Stuehr D. J. Comparative functioning of dihydro- and tetrahydropterins in supporting electron transfer, catalysis, and subunit dimerization in inducible nitric oxide synthase. Biochemistry. 1998 Jan 6;37(1):298–310. doi: 10.1021/bi971944c. [DOI] [PubMed] [Google Scholar]
  25. Rubanyi G. M., Vanhoutte P. M. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol. 1986 May;250(5 Pt 2):H822–H827. doi: 10.1152/ajpheart.1986.250.5.H822. [DOI] [PubMed] [Google Scholar]
  26. Schmidt P. P., Lange R., Gorren A. C., Werner E. R., Mayer B., Andersson K. K. Formation of a protonated trihydrobiopterin radical cation in the first reaction cycle of neuronal and endothelial nitric oxide synthase detected by electron paramagnetic resonance spectroscopy. J Biol Inorg Chem. 2001 Feb;6(2):151–158. doi: 10.1007/s007750000185. [DOI] [PubMed] [Google Scholar]
  27. Stroes E., Kastelein J., Cosentino F., Erkelens W., Wever R., Koomans H., Lüscher T., Rabelink T. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest. 1997 Jan 1;99(1):41–46. doi: 10.1172/JCI119131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Tiefenbacher C. P., Bleeke T., Vahl C., Amann K., Vogt A., Kübler W. Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosis. Circulation. 2000 Oct 31;102(18):2172–2179. doi: 10.1161/01.cir.102.18.2172. [DOI] [PubMed] [Google Scholar]
  29. Tiefenbacher C. P., Chilian W. M., Mitchell M., DeFily D. V. Restoration of endothelium-dependent vasodilation after reperfusion injury by tetrahydrobiopterin. Circulation. 1996 Sep 15;94(6):1423–1429. doi: 10.1161/01.cir.94.6.1423. [DOI] [PubMed] [Google Scholar]
  30. Ueda S., Matsuoka H., Miyazaki H., Usui M., Okuda S., Imaizumi T. Tetrahydrobiopterin restores endothelial function in long-term smokers. J Am Coll Cardiol. 2000 Jan;35(1):71–75. doi: 10.1016/s0735-1097(99)00523-9. [DOI] [PubMed] [Google Scholar]
  31. Vásquez-Vivar J., Hogg N., Martásek P., Karoui H., Pritchard K. A., Jr, Kalyanaraman B. Tetrahydrobiopterin-dependent inhibition of superoxide generation from neuronal nitric oxide synthase. J Biol Chem. 1999 Sep 17;274(38):26736–26742. doi: 10.1074/jbc.274.38.26736. [DOI] [PubMed] [Google Scholar]
  32. Vásquez-Vivar J., Kalyanaraman B., Martásek P., Hogg N., Masters B. S., Karoui H., Tordo P., Pritchard K. A., Jr Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9220–9225. doi: 10.1073/pnas.95.16.9220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Vásquez-Vivar J., Whitsett J., Martásek P., Hogg N., Kalyanaraman B. Reaction of tetrahydrobiopterin with superoxide: EPR-kinetic analysis and characterization of the pteridine radical. Free Radic Biol Med. 2001 Oct 15;31(8):975–985. doi: 10.1016/s0891-5849(01)00680-3. [DOI] [PubMed] [Google Scholar]
  34. Wolff D. J., Lubeskie A., Umansky S. The inhibition of the constitutive bovine endothelial nitric oxide synthase by imidazole and indazole agents. Arch Biochem Biophys. 1994 Nov 1;314(2):360–366. doi: 10.1006/abbi.1994.1454. [DOI] [PubMed] [Google Scholar]
  35. Zhang H., Joseph J., Vasquez-Vivar J., Karoui H., Nsanzumuhire C., Martásek P., Tordo P., Kalyanaraman B. Detection of superoxide anion using an isotopically labeled nitrone spin trap: potential biological applications. FEBS Lett. 2000 May 4;473(1):58–62. doi: 10.1016/s0014-5793(00)01498-8. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES